focus -WSS

focus

author：focus 2025-09-27 10:03:17 - browse：45483

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Risky weight loss products often used by teens globally, per study

leisure time

WSS

Three issues to watch in global health in 2024

Congress gives doctors Medicare pay bump

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Biotech companies concerned about China biosecurity crackdown

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

entertainment

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

knowledge

In age of alternative facts, a scholarly course on calling out crap

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Hollywood unions extend contract negotiations for actors

Covid isolation guidance eased by the CDC

Apple is now the first public company to be valued at $3 trillion

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Jerome Adams on the need for new antivirals for Covid

Heart disease and mental health: A look at cardiac psychology

At least 13 dead in Texas as scorching temps continue

Clinical trials giant ICON acquires HumanFirst

focus

The nurse manager staffing crisis is hurting patients

Caregivers of transplant patients call for more support, training

Medical device lobby: We're tired of waiting on Medicare coverage

Generative AI mines health records to identify patients’ social needs

Fauci’s Covid grilling leads GOP to weigh foreign research rules

HHS names first

leisure time

leisure time

focus

knowledge